A Dose-Ranging and Dose Frequency Study Evaluating the Safety and Efficacy of LIPO-102 for the Reduction of Abdominal Subcutaneous Adipose Tissue
Latest Information Update: 01 Apr 2015
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions
- Sponsors Neothetics
Most Recent Events
- 08 Aug 2014 New trial record